Brief: Exagen Inc. Reports Fourth Quarter And Full Year 2020 Results
March 16 (Reuters) - Exagen Inc XGN.O :
* . REPORTS FOURTH QUARTER AND FULL YEAR 2020 RESULTS
* Q4 REVENUE $12.7 MILLION VERSUS REFINITIV IBES ESTIMATE OF
$10.8
MILLION
* SEES FY 2021 REVENUE $47 MILLION TO $49 MILLION
* QTRLY LOSS PER SHARE $0.27
* Q4 EARNINGS PER SHARE VIEW $-0.41 -- REFINITIV IBES DATA
* FY2021 REVENUE VIEW $52.6 MILLION -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXS3ZHz
Further company coverage: XGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Exagen
See all newsUS RESEARCH ROUNDUP-Analog Devices, IBM, Qualcomm
Exagen Inc. reports results for the quarter ended June 30 - Earnings Summary
Exagen Q2 revenue beats on test volume growth; raises 2026 outlook
Exagen Inc expected to post a loss of 19 cents a share - Earnings Preview
Exagen beats Q1 revenue estimates, reaffirms 2026 guidance